NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Aronson N, Seidenfeld J, Samson DJ, et al. Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer. Rockville (MD): Agency for Health Care Policy and Research (US); 1999 May. (Evidence Reports/Technology Assessments, No. 4.)
This publication is provided for historical reference only and the information may be out of date.
Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer.
Show detailsEvidence Report Staff
- AHCPR Program Director
- Naomi Aronson, Ph.D.
- Systematic Review
- Jerome Seidenfeld, Ph.D., Project Director
- David J. Samson
- Meta-Analysis
- Victor Hasselblad, Ph.D.
- Cost-Effective Analysis
- Alan M. Garber, M.D., Ph.D.
- Adalsteinn Brown, A.B.
- Ahmed M. Bayoumi, M.D., M.Sc.
- Research/Editorial Staff
- Claudia J. Bonnell, B.S.N., M.L.S.
- Maurice Carter
- Maxine Gere, M.S.
- Lori D. Nickel
- Katheleen M. Ziegler, Pharm.D.
Technical Advisory Group
- Peter C. Albertsen, M.D.
- University of Connecticut Health Center
- Division of Urology
- Charles Bennett, M.D., Ph.D.
- Institute for Health Services Research
- Northwestern University
- Alan M. Garber, M.D., Ph.D.
- Stanford University School of Medicine;
- Division of General Internal Medicine
- Victor Hasselblad, Ph.D.
- Duke Clinical Research Institute
- Duke University
- Timothy J. Wilt, M.D., M.P.H.
- Section of General Medicine
- Minneapolis VA Medical Center
External Expert Reviewers
- Alex A. Adjei, M.D., Ph.D.
- Mayo Clinic
- Grant P. Bagley, M.D.
- Director, Coverage & Analysis Group
- Health Care Financing Administration
- Otis Brawley, M.D. a
- Director, Office of Special Populations, NCI
- Dr. Otilia Dalesio a
- Department of Biometrics,
- Netherlands Cancer Institute
- Prostate Cancer Trialists' Collaborative Group
- Chester Good, M.D., M.P.H.
- Pittsburgh VA Medical Center
- Manny Hamelburg
- Patient Representative nominated by the American Foundation for Urologic Diseases
- H. Logan Holtgrewe, M.D.
- Chair, Health Policy Council
- American Urological Association
- Gary Huckabay, Ph.D. a
- Cameron University
- Patient Representative nominated by the National Prostate Cancer Coalition
- Deborah A. Kuban, M.D.
- Eastern Virginia Medical School
- Nominated by the American Society for Therapeutic Radiology and Oncology
- Philip W. Kantoff
- Dana-Farber Cancer Institute
- Lank Center for Genitourinary Oncology
- Joseph Lau, M.D.
- Division of Clinical Care Research
- New England Medical Center
- EPC Project Director
- Henry A. Porterfield
- Patient Representative nominated by US TOO International
- Ian M. Thompson, Jr., M.D.
- Brook Army Medical Center
- John H. Wasson, M.D.
- Prostate Patient Outcomes Research Team
- Dartmouth Medical School
- Patrick C. Walsh, M.D.
- Urologist-in-Chief
- James Buchanan Brady Urological Institute
- The Johns Hopkins Hospital
- Nominated by the American Urological Association
- Jane Weeks, M.D.
- Dana-Farber Cancer Institute
- Nicholas J. Vogelzang, M.D.
- University of Chicago, Medical Center
- Section of Hematology/Oncology
- Nominated by the American Society of Clinical Oncology
- Anthony Zeitman, M.D.
- Massachusetts General Hospital
- Department of Radiation Oncology
- Pharmaceutical Companies
- Brian McMaster, RPh
- Hoescht Marion Roussel Canada
- Lisa Porter, M.D.
- Zeneca Pharmaceuticals
- Brian Niemi, RPh a
- TAP Pharmaceuticals
- Lily Chen, Pharm.D.
- Schering Laboratories
- John Wodtke, RPh a
- Hoeschst Marion Roussel
Blue Cross and Blue Shield Association Medical Advisory Panel
- Peter C. Albertsen, M.D.
- University of Connecticut Health Center
- Division of Urology
- James O. Armitage, M.D.
- University of Nebraska Medical Center
- Chairman Department of Internal Medicine
- Wade Aubry, M.D. (Chair)
- Blue Cross and Blue Shield Association
- National Medical Consultant
- J. Lawrence Colley, M.D.
- Corporate Medical Director
- Trigon Blue Cross Blue Shield
- Helen Darling, M.A.
- Practice Leader, Group Benefits & Health Care
- Watson Wyatt & Company
- Richard D. Dent, M.D.
- Blue Cross & Blue Shield of the Rochester Area
- Senior Vice President, Managed Care
- David M. Eddy, M.D., Ph.D.
- Kaiser Permanente
- Southern California Region
- Scientific Advisor for Health Policy and Management
- Alan M. Garber, M.D., Ph.D.
- Stanford Medical School
- Associate Professor of Medicine
- Kathleen Goonan, M.D.
- Blue Cross and Blue Shield of Massachusetts
- Vice President, Health Affairs
- Michael A. W. Hattwick, M.D.
- Woodburn Internal Medicine Associates, Ltd.
- I. Craig Henderson, M.D.
- University of California, San Francisco
- Professor of Medicine, Chief of Oncology
- Albert R. Jonsen, Ph.D.
- University of Washington
- Department of Medical History and Ethics
- Peter A. Margolis, M.D., Ph.D.
- University of North Carolina
- Department of Pediatrics, Assistant Professor
- Department of Epidemiology, Clinical Professor
- Barbara J. McNeil, M.D., Ph.D.
- Harvard Medical School
- Department of Health Care Policy
- Head of Health Care Policy
- Richard G. Roberts, M.D., J.D.
- University of Wisconsin School of Medicine
- Department of Family Medicine
- Earl P. Steinberg, M.D., M.P.P.
- Covance Health Economics & Outcomes Services, Inc.
- Clifford Waldman, M.D.
- Anthem Blue Cross & Blue Shield
- Medical Director
- Paul J. Wallace, M.D.
- Kaiser Permanente Northwest
- Les Zendle, M.D.
- Kaiser Permanente Southern California
- Associate Medical Director
- Acknowledgments - Relative Effectiveness and Cost-Effectiveness of Methods of An...Acknowledgments - Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer
- Homo sapiens novel putative protein similar to YIL091C yeast hypothetical 84 kD ...Homo sapiens novel putative protein similar to YIL091C yeast hypothetical 84 kD protein from SGA1-KTR7 (DJ434O14.5), mRNAgi|7657018|ref|NM_014388.1|Nucleotide
- Mus musculus vacuolar protein sorting 26 homolog A (yeast), mRNA (cDNA clone MGC...Mus musculus vacuolar protein sorting 26 homolog A (yeast), mRNA (cDNA clone MGC:6592 IMAGE:3485844), complete cdsgi|13938061|gb|BC007148.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...